cinacalcet has been researched along with Renal Insufficiency in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Honda, H; Koiwa, F; Mizobuchi, M; Ogata, H | 1 |
Boulware, LE; Chen, A; Ephraim, PL; Hall, R; Hwang, AS; Pendergast, J; Platt, A; Scialla, JJ; Weiner, DE; Wilson, J | 1 |
Hamano, T; Lim, K; Thadhani, R | 1 |
Chen, J; Huang, B; Jia, J; Li, Z; Lu, F; Shi, W; Tan, X; Zhang, M; Zhong, M | 1 |
Liu, BC; Liu, H; Pan, MM; Tang, RN; Wu, M; Xu, M | 1 |
Bjerknes, R; Netelenbos, C; Raeder, H; Shaw, N | 1 |
Bilezikian, JP; Silverberg, SJ | 1 |
Prié, D | 1 |
de Francisco, AL | 1 |
Bonny, O; Burnier, M | 1 |
5 review(s) available for cinacalcet and Renal Insufficiency
Article | Year |
---|---|
Vitamin D and Calcimimetics in Cardiovascular Disease.
Topics: Animals; Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Clinical Trials as Topic; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Renal Insufficiency; Vascular Calcification; Ventricular Remodeling; Vitamin D; Vitamin D Deficiency; Vitamins | 2018 |
The diagnosis and management of asymptomatic primary hyperparathyroidism.
Topics: Bone Diseases; Cardiovascular Diseases; Cinacalcet; Diphosphonates; Estrogens; Gastrointestinal Diseases; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Glands; Phosphates; Renal Insufficiency | 2006 |
[Hypercalcemia (with treatment)].
Topics: Adrenal Cortex Hormones; Aged; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcitriol; Calcium; Cinacalcet; Creatinine; Densitometry; Diphosphonates; Emergencies; Female; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Mutation; Naphthalenes; Parathyroid Hormone; Radionuclide Imaging; Receptors, Calcium-Sensing; Renal Insufficiency; Thyroid Hormones | 2006 |
New strategies for the treatment of hyperparathyroidism incorporating calcimimetics.
Topics: Animals; Calcium; Cinacalcet; Controlled Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Transplantation; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Renal Insufficiency | 2008 |
[Treatment of secondary hyperparathyroidism in renal insufficiency: role of calcitriol, sevelamer and cinacalcet].
Topics: Calcitriol; Chelating Agents; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Naphthalenes; Polyamines; Renal Insufficiency; Sevelamer; Vitamin D Deficiency; Vitamins | 2008 |
1 trial(s) available for cinacalcet and Renal Insufficiency
Article | Year |
---|---|
Pharmacokinetics and pharmacodynamics of cinacalcet in patients with renal failure receiving hemodialysis and hemodiafiltration therapy
.
Topics: China; Cinacalcet; Hemodiafiltration; Humans; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency; Tandem Mass Spectrometry | 2019 |
4 other study(ies) available for cinacalcet and Renal Insufficiency
Article | Year |
---|---|
Early response of the parathyroid gland to withdrawal of a calcimimetic compound in uremic rats.
Topics: Animals; Calcitriol; Cinacalcet; Hyperparathyroidism, Secondary; Male; Nephrectomy; Parathyroid Glands; Rats; Rats, Sprague-Dawley; Renal Insufficiency | 2020 |
Trends in Mineral Metabolism Treatment Strategies in Patients Receiving Hemodialysis in the United States.
Topics: Aged; Calcimimetic Agents; Calcium-Regulating Hormones and Agents; Cinacalcet; Drug Prescriptions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minerals; Parathyroid Hormone; Phosphates; Practice Patterns, Physicians'; Renal Dialysis; Renal Insufficiency; Sterols; United States; Vitamin D | 2020 |
Cinacalcet attenuates the renal endothelial-to-mesenchymal transition in rats with adenine-induced renal failure.
Topics: Adenine; Animals; Cell Differentiation; Cholesterol 7-alpha-Hydroxylase; Cinacalcet; Endothelial Cells; Kidney; Liver; Male; Mesenchymal Stem Cells; Naphthalenes; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Insufficiency; RNA, Messenger | 2014 |
A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet.
Topics: Administration, Oral; Bone Density Conservation Agents; Cinacalcet; Familial Hypophosphatemic Rickets; Female; Genetic Diseases, X-Linked; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism; Hypertension; Infant; Mutation, Missense; Naphthalenes; Nephrocalcinosis; PHEX Phosphate Regulating Neutral Endopeptidase; Phosphates; Renal Insufficiency | 2008 |